LIQUID BIOPSY
Clinical trials for LIQUID BIOPSY explained in plain language.
Never miss a new study
Get alerted when new LIQUID BIOPSY trials appear
Sign up with your email to follow new studies for LIQUID BIOPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Urine DNA test may let some bladder cancer patients stop immunotherapy early
Disease control Recruiting nowThis study tests whether a urine DNA test can help guide when to stop immunotherapy in people with a very high-risk type of bladder cancer that cannot be fully removed by surgery. About 53 participants will receive immunotherapy and then be monitored with urine tests and scans. I…
Matched conditions: LIQUID BIOPSY
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
Urine test could spare bladder cancer patients from unnecessary surgery
Diagnosis Recruiting nowThis study looks at whether a urine test that detects tumor DNA and RNA can guide doctors in deciding which patients with high-risk non-muscle-invasive bladder cancer truly need a second surgery. Currently, many patients undergo a repeat procedure, but it may not benefit everyone…
Matched conditions: LIQUID BIOPSY
Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 15, 2026 19:08 UTC
-
Urine test may spare bladder cancer patients from unnecessary second surgery
Diagnosis Recruiting nowThis study looks at whether a simple urine test for tumor DNA can tell which bladder cancer patients truly need a second surgery after their first tumor removal. About 196 adults with non-muscle-invasive bladder cancer will be randomly assigned to have their repeat surgery decisi…
Matched conditions: LIQUID BIOPSY
Phase: NA • Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 11, 2026 11:57 UTC